Age, yearsa | n (%) |
---|---|
15–19 | 38 (12) |
20–24 | 22 (7) |
25–29 | 54 (16) |
30–34 | 69 (21) |
35–39 | 60 (18) |
≥40 | 87 (26) |
Ethnic group a | |
White | 150 (45) |
Black | 49 (15) |
South Asian | 87 (26) |
Other | 22 (7) |
Unknown | 22 (7) |
Received pre-conception or contraception advice b | 151 (46) |
Prescribed contraception b | 90 (27) |
Prescribed LARCc | 48 (53) |
Prescribed non-LARCc | 42 (47) |
Received advice or contraception b | 191 (58) |
aData relate to most recent record for age and ethnic group. bAt least once during study period. cLong-acting reversible contraception (LARC): copper intrauterine device, levonorgestrel 13.5 mg/19.5 mg/52 mg intrauterine system, and progestogen-only implant. Non-LARC contraception: combined hormonal contraception including combined contraceptive pill, transdermal patch and vaginal ring, progestogen-only pill, progestogen-only injectable depot medroxyprogesterone acetate, condoms, and diaphragms.